These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28523792)

  • 1. The impact of calcineurin inhibitors on neutrophil gelatinase-associated lipocalin and fibroblast growth factor 23 in long-term kidney transplant patients.
    Bleskestad IH; Thorsen IS; Jonsson G; Skadberg Ø; Gøransson LG
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28523792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients.
    Bleskestad IH; Thorsen IS; Jonsson G; Skadberg Ø; Bergrem H; Gøransson LG
    Eur J Endocrinol; 2015 Apr; 172(4):343-50. PubMed ID: 25572388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23, NGAL, and Endostatin: the Predictors of Allograft Function in Renal Transplant Recipients.
    Gürlek Demirci B; Sezer S; Uyanık Yıldırım S; Kaynar Erdoğan M; Tutal E; Özdemir Ö; Orazbayev G; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):136-139. PubMed ID: 29528011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy.
    Stypmann J; Fobker M; Rosing K; Engelen M; Gunia S; Dell'Aquila AM; Nofer JR
    J Cardiol; 2015 Oct; 66(4):347-52. PubMed ID: 25583090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.
    Jia XY; Wei K; Chen J; Xi LH; Kong XL; Wei Y; Wang L; Wang ZS; Liu YP; Liang LM; Xu DM
    J Bone Miner Metab; 2021 Nov; 39(6):1058-1065. PubMed ID: 34392464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.
    Alpay N; Ozkok A; Caliskan Y; Akagun T; Cinar SA; Deniz G; Sariyar M; Yildiz A
    Clin Exp Nephrol; 2014 Dec; 18(6):961-7. PubMed ID: 24515306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
    Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.
    Olauson H; Lindberg K; Amin R; Sato T; Jia T; Goetz R; Mohammadi M; Andersson G; Lanske B; Larsson TE
    PLoS Genet; 2013; 9(12):e1003975. PubMed ID: 24348262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Stroda A; Brandenburg V; Daher A; Cornelissen C; Goettsch C; Keszei A; Dreher M
    Respir Res; 2018 Sep; 19(1):183. PubMed ID: 30236113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
    Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
    Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women.
    Xu Y; Ma X; Pan X; He X; Xiao Y; Bao Y
    Cardiovasc Diabetol; 2018 Nov; 17(1):143. PubMed ID: 30424752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
    Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year retrospective study of the effect of preemptive kidney transplantation and pretransplant mineral bone factors on calcium in post-kidney transplant recipients.
    Tsujita M; Goto N; Futamura K; Okada M; Hiramitsu T; Narumi S; Uchida K; Morozumi K; Watarai Y
    Clin Exp Nephrol; 2020 Sep; 24(9):836-841. PubMed ID: 32342291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal phosphate loss in long-term kidney transplantation.
    Sirilak S; Chatsrisak K; Ingsathit A; Kantachuvesiri S; Sumethkul V; Stitchantrakul W; Radinahamed P; Disthabanchong S
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):323-31. PubMed ID: 22134626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.